We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+561.53%
AUM
$880B
AUM Growth
+$147B
Cap. Flow
+$97B
Cap. Flow %
11.02%
Top 10 Hldgs %
14.5%
Holding
8,205
New
199
Increased
3,814
Reduced
2,948
Closed
311

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$3.71B
2
MSFT icon
Microsoft
MSFT
+$3.52B
3
AMZN icon
Amazon
AMZN
+$2.04B
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$1.87B
5
LLY icon
Eli Lilly
LLY
+$1.31B

Sector Composition

Rank Sector Weight
1 Technology 17.3%
2 Healthcare 12.11%
3 Financials 10.63%
4 Consumer Discretionary 8.09%
5 Industrials 6.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUSL icon
6951
iShares ESG MSCI USA Leaders ETF
SUSL
$1.22B
$3.98K ﹤0.01%
60
NMTR
6952
DELISTED
9 Meters Biopharma
NMTR
$3.97K ﹤0.01%
3,154
-1,980
-39% -$4.51K
CCLD icon
6953
CareCloud
CCLD
$104M
$3.95K ﹤0.01%
1,407
-18,986
-93% -$65.6K
CFRX
6954
DELISTED
ContraFect Corporation
CFRX
$3.94K ﹤0.01%
513
+400
+354% +$4.63K
XWEB
6955
DELISTED
SPDR S&P Internet ETF
XWEB
$3.92K ﹤0.01%
63
LSTA icon
6956
Lisata Therapeutics
LSTA
$10.2M
$3.92K ﹤0.01%
1,549
+133
+9% +$488
USOI icon
6957
Credit Suisse AG Credit Suisse X-Links Crude Oil Shares Covered Call ETN
USOI
$42M
$3.91K ﹤0.01%
47
EPHY
6958
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
$3.9K ﹤0.01%
390
-66
-14% -$659
ELTX icon
6959
Elicio Therapeutics
ELTX
$82.7M
$3.88K ﹤0.01%
479
-161
-25% -$1.46K
LANV.WS
6960
DELISTED
Lanvin Group Holdings Warrants
LANV.WS
$3.88K ﹤0.01%
+12,928
New +$3.39K
AYTU icon
6961
AYTU BioPharma
AYTU
$24.7M
$3.87K ﹤0.01%
1,025
+1
+0.1% +$4
ATXI
6962
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$3.87K ﹤0.01%
44
+24
+120% +$4.35K
USD icon
6963
ProShares Ultra Semiconductors
USD
$2.99B
$3.86K ﹤0.01%
932
ACOR
6964
DELISTED
Acorda Therapeutics
ACOR
$3.82K ﹤0.01%
249
-86
-26% -$1K
SPYC icon
6965
Simplify US Equity PLUS Convexity ETF
SPYC
$121M
$3.81K ﹤0.01%
150
OG
6966
DELISTED
Onion Global Limited American Depositary Shares (each ten (10) ADSs representing one (1) Class A Ordinary Share)
OG
$3.79K ﹤0.01%
+15,150
New +$3.92K
DBV
6967
DELISTED
Invesco DB G10 Currency Harvest Fund
DBV
$3.79K ﹤0.01%
150
ALZN icon
6968
Alzamend Neuro
ALZN
$7M
$3.77K ﹤0.01%
5
+2
+67% +$2.9K
ROI
6969
DELISTED
RiskOn International, Inc. Common Stock
ROI
$3.76K ﹤0.01%
545
MOGU
6970
MOGU Inc
MOGU
$16.3M
$3.75K ﹤0.01%
1,518
ZDGE icon
6971
Zedge
ZDGE
$38.9M
$3.75K ﹤0.01%
2,129
-3,682
-63% -$7.96K
CGGO icon
6972
Capital Group Global Growth Equity ETF
CGGO
$12.1B
$3.72K ﹤0.01%
+177
New +$3.62K
CEW
6973
WisdomTree Emerging Currency Strategy Fund
CEW
$17.8M
$3.71K ﹤0.01%
220
-150
-41% -$2.46K
SPCK
6974
The SPAC and New Issue ETF
SPCK
$8.3M
$3.69K ﹤0.01%
150
-5,641
-97% -$146K
SPRB
6975
Spruce Biosciences
SPRB
$143M
$3.66K ﹤0.01%
45
-264
-85% -$22.1K

Similar funds

Morgan Stanley's Q4 2022 Portfolio in Review

As of Q4 2022, Morgan Stanley held 8,205 positions worth $880B, up 20% from $734B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Morgan Stanley deployed $97B of net new capital in Q4 2022, opening 199 new positions and adding to 3,814 existing holdings. Its largest new stake was Rentokil: 2,829,958 shares worth $87.2M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.8B trimmed.

  • Morgan Stanley's largest Q4 2022 buy was Rentokil: 2,829,958 shares worth $87.2M.
  • Morgan Stanley added most to Apple in Q4 2022, an estimated $3.71B increase.
  • Morgan Stanley's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.8B.
  • Morgan Stanley fully exited Twitter, Inc. in Q4 2022, selling an estimated $348M.
  • Morgan Stanley's ten largest holdings make up 14% of its $880B portfolio in Q4 2022.
  • Morgan Stanley opened 199 new positions and closed 311 in Q4 2022.
  • Morgan Stanley's portfolio value rose 20% quarter-over-quarter to $880B.

Based on Morgan Stanley's 13F filing for Q4 2022, filed 14 Feb 2023.